We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $726M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+12.51%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$544M
AUM Growth
+$39.6M
Cap. Flow
-$12.9M
Cap. Flow %
-2.38%
Top 10 Hldgs %
51.79%
Holding
81
New
3
Increased
17
Reduced
45
Closed
–

Top Buys

Rank Stock Value
1
COST icon
Costco
COST
+$2M
2
CMG icon
Chipotle Mexican Grill
CMG
+$1.37M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$685K
4
FISV
Fiserv Inc
FISV
+$656K
5
MSFT icon
Microsoft
MSFT
+$541K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.63M
2
NVDA icon
NVIDIA
NVDA
+$1.93M
3
PCRX icon
Pacira BioSciences
PCRX
+$1.11M
4
AMT icon
American Tower
AMT
+$1.05M
5
SYK icon
Stryker
SYK
+$1M

Sector Composition

Rank Sector Weight
1 Technology 32.71%
2 Healthcare 19.91%
3 Consumer Discretionary 12.07%
4 Communication Services 8.19%
5 Consumer Staples 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZN icon
51
AstraZeneca
AZN
$263B
$1.5M 0.28%
10,441
+1,344
+15% +$198K
WMT icon
52
Walmart Inc
WMT
$885B
$928K 0.17%
17,739
-1,200
-6% -$60.5K
QCOM icon
53
Qualcomm
QCOM
$155B
$913K 0.17%
7,670
– –
ADI icon
54
Analog Devices
ADI
$179B
$889K 0.16%
4,557
+2,141
+89% +$396K
ABBV icon
55
AbbVie
ABBV
$443B
$870K 0.16%
6,442
-361
-5% -$52.9K
ETN icon
56
Eaton
ETN
$161B
$755K 0.14%
3,755
– –
NVS icon
57
Novartis
NVS
$297B
$649K 0.12%
6,424
-80
-1% -$8K
ASML icon
58
ASML
ASML
$626B
$623K 0.11%
859
+232
+37% +$158K
PCRX icon
59
Pacira BioSciences
PCRX
$1.04B
$598K 0.11%
14,953
-26,735
-64% -$1.11M
AMGN icon
60
Amgen
AMGN
$208B
$583K 0.11%
2,624
– –
UNH icon
61
UnitedHealth
UNH
$376B
$571K 0.11%
1,188
– –
K
62
DELISTED
Kellanova
K
$537K 0.1%
8,541
– –
AMT icon
63
American Tower
AMT
$80.8B
$448K 0.08%
2,311
-5,372
-70% -$1.05M
MRK icon
64
Merck
MRK
$322B
$405K 0.07%
3,523
– –
KO icon
65
Coca-Cola
KO
$377B
$403K 0.07%
6,724
– –
HSY icon
66
Hershey
HSY
$35.2B
$373K 0.07%
1,492
– –
TGT icon
67
Target
TGT
$65.6B
$353K 0.06%
2,673
– –
CSCO icon
68
Cisco
CSCO
$457B
$349K 0.06%
6,715
– –
EOG icon
69
EOG Resources
EOG
$79.2B
$292K 0.05%
2,564
-170
-6% -$19.4K
MRSH
70
Marsh
MRSH
$90.5B
$285K 0.05%
1,517
– –
EMR icon
71
Emerson Electric
EMR
$83.9B
$284K 0.05%
3,157
-100
-3% -$8.42K
BDX icon
72
Becton Dickinson
BDX
$45.6B
$260K 0.05%
986
– –
TTC icon
73
Toro Company
TTC
$8.75B
$251K 0.05%
2,457
+635
+35% +$65.1K
BMY icon
74
Bristol-Myers Squibb
BMY
$133B
$243K 0.04%
3,790
-15
-0.4% -$1.01K
UPS icon
75
United Parcel Service
UPS
$88.6B
$235K 0.04%
1,313
-75
-5% -$13.3K
1 2
3
4

Similar funds

TC
Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return
F
FIFTHDELTA London, United Kingdom $725M AUM 11.7% 1-Year Est. Return
SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
SCM
SKBA Capital Management San Francisco, California $728M AUM 12.18% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $729M AUM 15.61% 1-Year Est. Return
FAN
Financial Advisors Network Tustin, California $724M AUM 14.91% 1-Year Est. Return
TFHU
TLT Family Holdco ULC Toronto $724M AUM 24.23% 1-Year Est. Return
AGAM
Avalon Global Asset Management San Francisco, California $724M AUM 52.97% 1-Year Est. Return

Dillon & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Dillon & Associates held 81 positions worth $544M, up 7.9% from $504M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 3.7%. Dillon & Associates opened 3 new positions and made no exits, leaving the 81-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Dillon & Associates's largest Q2 2023 buy was Agree Realty: 3,235 shares worth $210K.
  • Dillon & Associates added most to Costco in Q2 2023, an estimated $2M increase.
  • Dillon & Associates's biggest Q2 2023 reduction was Apple, cutting an estimated $4.63M.
  • Dillon & Associates's ten largest holdings make up 52% of its $544M portfolio in Q2 2023.
  • Dillon & Associates opened 3 new positions and closed 0 in Q2 2023.
  • Dillon & Associates's portfolio value rose 7.9% quarter-over-quarter to $544M.

Based on Dillon & Associates's 13F filing for Q2 2023, filed 8 Aug 2023.